Objective: The purpose of this randomized trial was to investigate the efficacy of 2 behavioral treatments focusing on different change mechanisms in ameliorating a borderline personality disorder constellation of behaviors and substance use in adolescents referred by juvenile diversion programs. Methods: Forty adolescents 14 -17 years of age and meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed.) criteria for borderline personality disorder and substance use disorders were randomized to integrative borderline personality disorder-oriented adolescent family therapy (I-BAFT) or individual drug counseling. This design allowed a comparison of 2 manualized interventions, 1 family based and 1 individually oriented. Profiles of clinical change were used to detect impact and estimate treatment effect sizes. Results: Primary analyses showed that both interventions had a clinically significant impact on borderline personality disorder behaviors 12 months after baseline but with no differential treatment effects. The impact on substance use was more complex. Subgroup analyses revealed that adolescents with depression had significantly more severe profiles of borderline personality disorder and substance use. These youths were the only group to show reductions in substance use, but they only did so if they received the I-BAFT intervention. Study data also documented the high dosage of intensive residential treatment needed by this population. Conclusions and Implications for Practice: Results highlight the intensive treatment needs of juvenile justice-involved youths with co-occurring substance use and borderline personality disorder including depression, the hybrid outpatient and residential treatment often required by this population, and the promise of a family-oriented approach, particularly for youths with severe symptoms and co-occurring depression.
there is not always agreement on whether adolescents should be diagnosed with borderline personality disorder, these studies have shown that it is possible to identify adolescents displaying a profile of co-occurring substance use, impulsivity, and self-harm behaviors that often require multiple residential/inpatient hospitalizations and that endure over time if not properly treated. The handful of available randomized trials with adolescents with subsyndromal or full-syndromal borderline personality disorder have reported mixed results suggesting reduced borderline personality disorder symptoms but few differential treatment effects (Chanen et al., 2008; Schuppert et al., 2009) .
Comorbid depression has emerged as a particularly interesting and impactful condition. A meta-analysis by Newton-Howes, Tyrer, and Johnson (2006) found that individuals with cooccurring personality disorder and depression were about twice as likely to have worse treatment outcomes. Less evidence exists for adolescents, but Warden et al. (2012) showed that adolescents in treatment for drug use with co-occurring depression reported more drug use at baseline and higher use throughout the course of treatment. It is interesting to note that there is some evidence that family-based treatments may be particularly useful for adolescents with the most severe profiles of substance use and psychiatric comorbidity (Henderson, Dakof, Greenbaum, & Liddle, 2010) .
The comparison of interventions based on different frameworks can be useful in identifying the best possible treatment for substance abuse in adolescents. Because of the likelihood that borderline behavior and substance use can easily trigger each other, we sought to develop a treatment that would combine one of the most effective interventions for adolescent substance abuse (i.e., family therapy) with components of one of the most effective interventions for borderline personality disorder (i.e., dialectical behavior therapy [DBT] skills). The newly developed intervention sought to address both problems simultaneously through individual and family-focused work (integrative borderline personality disorderoriented adolescent family therapy [I-BAFT]; Santisteban, Muir, Mena, & Mitrani, 2003 ). An alternative treatment approach is to focus squarely on the primary symptom of substance use. Individual drug Counseling (IDC) is a manualized intervention originally designed for adults but used with adolescents with opioid dependence in a National Institute on Drug Abuse study (Subramaniam et al., 2011) . IDC is based on the 12-step philosophy, which conceptualizes addiction as a complex problem that damages the substance-using individual physically, mentally, and spiritually (Mercer & Woody, 1999) . The IDC treatment can address depression and other relevant emotions that emerge as triggers to use, but it is not specifically designed to do so.
The purpose of this randomized trial was to investigate the efficacy of two behavioral treatments for adolescents with borderline personality disorder and substance abuse. We compared two bona fide manualized treatments with equivalent dosage but different targets for intervention (family based and focused on cooccurring psychiatric disorders vs. individually based and focused almost exclusively on drug use). All of the participants met criteria for substance abuse and borderline personality disorder, but only a third (38%) had comorbid depression. This profile allowed us to investigate how depression might affect all of our variables of interest. The research objectives of this study were to investigate (a) the clinical and drug use profile of our sample; (b) the feasibility and acceptability (therapeutic alliance and outpatient sessions received) of individual and family treatments in this sample; (c) whether I-BAFT was more effective at changing borderline behaviors and substance use than IDC; and (d) the amount of intensive and emergency residential treatment needed, in addition to outpatient sessions, to address the severe clinical profile of this sample. In addition, for each of the research questions above, we also investigated the effect of comorbid depression.
Method Participants
Forty adolescents ages 14 to 17 years who met Diagnostic and Statistical Manual of Mental Disorders (4th ed. [DSM-IV]; American Psychiatric Association, 1994) criteria for substance abuse and borderline personality disorder were included in the study. It should be noted that an adolescent could meet the eligibility criteria for substance use disorder on the basis of the last 12 months, even if there was no documented use in the past 30 days. This sample size of 15-30 cases per condition is consistent with guidelines for the early-stage testing of new innovative treatments (Rounsaville, Carroll, & Onken, 2001 ). The adolescents and at least one caregiver in each family participated in assessments and treatment at a university center in south Florida. Characteristics of adolescents and primary caregivers are shown in Table 1 . Sixtyfive percent of the youths reported being arrested or detained at a police station during the past year. About two-thirds of youths were referred from the juvenile justice system: 38% from the Miami-Dade Juvenile Services Department (JSD) and 32% from a juvenile addictions receiving facility (JARF; 30% were referred by school counselors or the community in general).
Participants referred through JSD were in diversion programs that focused on youths who had committed a minor first-time misdemeanor offense. Although not formally arrested, the youths from JSD were assigned a case worker and were evaluated to Note. There were no differences between intervention conditions at p Ͻ .05. I-BAFT ϭ integrative borderline personality disorder-oriented adolescent family therapy; IDC ϭ individual drug counseling. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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determine their individual needs. Adolescents are also required to comply with specific program mandates, including completing community service hours, attending school or being legally employed, and receiving treatment for mental health and/or substance abuse issues when appropriate. Youths were monitored by a JSD case worker for approximately 4 months. The JARF is a secure, locked facility that provides assessment and referral to youths who are using alcohol and drugs. Youths enter the JARF either voluntarily or involuntarily (e.g., court order through the Florida Marchman Act, JSD), are in crisis due to substance abuse, and remain at the JARF for 3-5 days. Through a comprehensive assessment, the JARF determines a youth's treatment needs and assists with placement in appropriate intervention programs prior to discharge. Youths who are involuntarily placed there are required to comply with the JARF assessment and to receive the assigned treatment. The court may impose legal consequences for lack of compliance.
Procedures
The study was approved by the university institutional review board, and all participating family members provided written consent or assent. It is important to note that although the participants referred from JSD and the JARF were legally required to receive treatment, our program was voluntary. All participants were informed that they had the right to refuse to participate in research and could be offered treatment outside of a research study. This was also explained in the informed consent document, which parents and youths signed prior to enrollment.
All procedures and treatments were offered in English or Spanish. After completing the intake assessment, participants were assigned to one of two conditions using permuted block randomization: I-BAFT or IDC. Randomization was stratified by gender, race/ethnicity, and drug use severity in the past 30 days. Data were collected at baseline, 4 months, 8 months, and 12 months postbaseline at the university center. See Figure 1 for a flow diagram of participants in this trial, using CONSORT (Consolidated Standards of Reporting Trials) guidelines.
Measures
Measures were selected that had strong psychometric properties and were available in Spanish and English. Bachelor's-level assessors with several years of experience and who were fluent in Spanish and English completed all interviews with participants. Assessors were not blind to the intervention.
Borderline personality disorder diagnosis. Borderline personality disorder diagnosis was determined at baseline using the Revised Diagnostic Interview for Borderlines (Kolb & Gunderson, 1980) , a semistructured interview that assesses five functional areas: social adaptation, impulse/action patterns, affect, psychosis, and interpersonal relations.
Therapeutic alliance. Therapeutic alliance between the therapist and the adolescent was measured using adolescent and therapist reports from the Working Alliance Inventory (Horvath & Greenberg, 1989) , which were collected on a monthly basis during the intervention. This instrument measures the level of collaboration, agreement, and emotional connection between therapist and client. Items were rated on a seven-point Likert-type scale ranging from 1 (never) to 7 (always) and were averaged into single total scores separately for therapists and adolescents. The reliability for the total score used in this study ranged from .95 to .98 for client reports and .91 to .96 for therapist reports. To correct for extreme negative skew in the alliance scores, both therapist and client reports were transformed into two separate categorical variables.
Outpatient sessions. Outpatient sessions were defined by the number of planned sessions received as part of either intervention condition during the treatment phase. In I-BAFT, sessions could be family, individual, or skills-building sessions. In IDC, all but a few sessions were individual sessions. Any services that were received outside of this study were not included in this count.
Borderline personality disorder behavior. A dimensional score of the borderline personality disorder constellation was obtained using the adolescent report on the Borderline Personality scale from the Millon Adolescent Clinical Inventory (MACI; Millon, 1993) . The base rate was calculated using gender and age norms. In this sample, reliability was good at all assessments (␣s range: .78 -.88). For analysis, a dichotomous variable was created: Borderline personality disorder behavior was coded as not functional (base rate Ͼ 60) versus functional (base rate Յ 60).
Depression. Depression was measured with the Diagnostic Interview Schedule for Children-Predictive Scales (DPS; Lucas This document is copyrighted by the American Psychological Association or one of its allied publishers.
et al., 2001), a brief screening instrument that was administered at baseline and matched to DSM-IV diagnoses a child would "likely" receive if given a full diagnostic interview. Adolescents and caregivers were interviewed separately using the structured interview, and adolescents were categorized as having depression at baseline if they met criteria on either caregiver or adolescent reports-that is, the participant was given the diagnosis if either the parent or adolescent endorsed the requisite number of symptoms for each disorder. For this study, the DPS covered 30 days before baseline. Substance use. Substance use was measured using the Timeline Followback (TLFB; Sobell et al., 2003) and urine toxicology. The TLFB obtains retrospective adolescent reports of daily substance use, with a 30-day calendar to stimulate recall, and gathers information on specific substances used and days used; it has been used with juvenile justice populations (Halliday-Boykins et al., 2010) . A urine sample was collected from each participant up to twice monthly (after treatment sessions chosen randomly) and at each of the main assessment time points. Urine samples were sent to a certified laboratory for analyses to identify amphetamine, marijuana, cocaine, opiate, phencyclidine, methamphetamine, barbiturate, and benzodiazepine use. For certain analysis, the TLFB and urine toxicology were combined into a single dichotomous variable: substance use was coded as positive for a single time point if any of the samples were positive for use or there was any self-reported use and negative if all of the samples were negative for use and there was no self-reported use.
Residential days of treatment. Data on several types of services were collected at baseline and every 2 months postbaseline to investigate the types of emergency services typically needed by this population. Hospitalization for psychiatric problems and residential treatment for deteriorating drug problems were combined into a single residential treatment category. This category includes residential treatment received during two periods: during the treatment and during follow-up phases.
Interventions I-BAFT. I-BAFT is a manualized treatment that adapts individual interventions and skills training modules from DBT (Linehan, 1993) and family interventions from structural family therapy (Minuchin & Fishman, 1981) . I-BAFT targets factors that directly contribute to adolescent drug abuse and other self-harm behaviors such as emotion dysregulation and impulsivity, failure to establish life goals and ineffective life skills, unstable family attachment, and maladaptive family interactions (Santisteban, Muir, et al., 2003) . I-BAFT delivered weekly family therapy, individual therapy, and skills-building interventions in a two-session-per-week format over a 7-month period. One family session and either a skills training or an individual session with the adolescent were scheduled weekly. Separate therapists and skills trainers were used, as recommended for DBT (Linehan, 1993) . In this study each I-BAFT therapist serves as the primary therapist for half of the participating families and as the skills trainer for the other half of the families. Thus each therapists in the study took on both roles. Therapists were trained by I-BAFT's developer.
IDC. IDC was an active and bona fide comparison condition in this study. IDC is a manualized individually oriented substance abuse intervention that has been used with both adults and adolescents (Subramaniam et al., 2011) . The foundation of IDC is the 12-step philosophy, which seeks to address addiction from the physical, mental, and spiritual perspectives (Mercer & Woody, 1999 ). An experienced trainer from the team that developed the IDC intervention conducted the training for the IDC clinicians in the study. IDC was administered in a two-session-per-week format implemented over a 7-month period that matched the dosage in the I-BAFT condition. All sessions were conducted as individual sessions with the adolescent except for a monthly family meeting with caregivers. Goals of the IDC manual include the following: (a) identifying signs and symptoms of addiction and triggers to use; (b) recognizing and rechanneling urges to use drugs; (c) increasing motivation to achieve and sustain abstinence; (d) becoming accountable for episodes of use; (e) developing new and more effective problem-solving strategies; (f) connecting with the 12-step philosophy and participating in Narcotics Anonymous, Alcoholics Anonymous, and /or Cocaine Anonymous; and (g) improving self-esteem by practicing newly acquired coping skills and problem-solving strategies at home and in the community (Mercer & Woody, 1999) .
Therapists
Therapists for the two conditions were eight master's-level and doctoral-level therapists with substantial experience in the treatment of substance-abusing adolescents. Each therapist was trained by an expert in their respective conditions and met weekly with a supervisor and fellow therapists to view videotaped therapy sessions and to discuss the implementation of the manualized interventions with a high degree of adherence and fidelity. Therapists were nested in conditions, with four therapists delivering IDC and four therapists delivering I-BAFT.
Results

Participant's Clinical Profiles at Baseline
Preliminary analyses focused on the characteristics of adolescents and their caregivers at baseline and also tested for any pretreatment differences between participants in the two intervention conditions. Because of the small sample size of this study, analyses relied on clinical change and effect sizes to detect promising treatment patterns worthy of further research. Baseline profiles of adolescent substance use and borderline personality disorder behaviors are found in Table 2 . Substance use was fairly even across the two conditions, although there was a nonsignificant trend for differences between conditions. All participants reported that they had used marijuana and alcohol in their lifetime; over half reported lifetime cocaine use. Recent (past 30 days) marijuana use was reported by 85% of the sample; 56% reported recent alcohol use. Youths reported severe symptoms; 11 (28%) adolescents had been in residential treatment in the year prior to the study, with an average stay of 37.27 days (SD ϭ 37.89), but clearly symptoms persisted.
Subgroups Based on Comorbid Depression
We conducted subgroup analyses, with the sample divided into adolescents with and without comorbid depression. Adolescents with depression had significantly greater self-reported substance This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Feasibility and Acceptability
Therapeutic alliance. We tested for differences in the therapeutic alliance (as reported by adolescents and therapists) between the two intervention conditions. Generalized estimating equations were used to account for repeated measures across time when analyzing differences in therapeutic alliance scores. Most therapists (91%) and adolescents (84%) reported high alliance throughout therapy in both conditions. There was no difference between conditions in adolescent-reported alliance, B ϭ Ϫ1.08, SE ϭ 0. Outpatient sessions received. Participants in both conditions attended a considerable number of outpatient sessions (IDC: M ϭ 20.90, SD ϭ 12.07; I-BAFT: M ϭ 27.15, SD ϭ 14.76). The distribution of types of sessions (individual, family, and skills focused) was consistent with the parameters of the distinct interventions and the research design. That is, participants in IDC received significantly more individual sessions and significantly fewer family sessions and skills sessions than did the I-BAFT participants. Analyses of variance were used to examine differences in the number of outpatient sessions each adolescent and family received. The total number of sessions was not different between the two conditions, F(1, 38) ϭ 2.15, p ϭ .151. 
Profiles of Clinical Change
Differential treatment effects were investigated using an analysis of the profile of clinical change in substance use and analysis of clinically significant change (Jacobson & Truax, 1991) in bor- Note. I-BAFT ϭ integrative borderline personality disorder-oriented adolescent family therapy; IDC ϭ individual drug counseling; BDP ϭ borderline personality disorder. a One participant in I-BAFT refused to report level of substance use at baseline.
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derline personality disorder behavior from baseline to the 12 month follow-up. Our substance use measure did not allow for the formal steps recommended by Jacobson and Truax, but we replicated a strategy used successfully in similar adolescent drug treatment trials (e.g., Santisteban, Coatsworth, et al., 2003) . Each analysis was conducted first using the overall sample and then separately for the depressed and nondepressed groups. The formal analysis of clinical significance involved two steps: (a) determining whether participants had statistically reliable change and (b) categorizing participants according to clinical cut-points. Different definitions of change-that is, different cut-points-were used for substance use and borderline personality disorder behavior. Definition of change in borderline personality disorder behavior. Using the more formal criteria for clinically significant change for borderline personality disorder behavior, participants were categorized as follows: (a) recovered-participants with scores in the clinical range at intake with statistically reliable reductions in scores and MACI base rates of less than 60 at the 12-month follow-up; (b) improved-participants with statistically reliable reduction in scores but with scores in the clinical range at follow-up; (c) unchanged, nonclinical-participants who did not show statistically reliable change in scores but were not in the clinical range at follow-up; (d) unchanged, clinical-participants who did not show statistically reliable change in scores and remained in the clinical range at follow-up; and (e) deteriorated-participants with statistically reliable increases in scores at follow-up.
Definition of change in substance use. For substance use, participants were first categorized into four levels of drug use that have been previously used in the substance use treatment literature (Brook et al., 1998; Santisteban, Coatsworth, et al., 2003) . The categories were based on adolescent-reported substance use at baseline and the 12-month follow-up. They are as follows: abstinence (no substance use), weekly use (1-8 days of use), frequent use (9 -16 days of use), and daily use (17 or more days of use). These categories, along with urine toxicology, were then used to calculate clinical change. A more formal test of clinically significant change was not possible because of the absence of normative and reliability information for self-reported substance use. For our change profile, participants were categorized as follows: (a) recovered-participants reporting decreased use (moving to a category representing less use), with a negative urine screen and self-reported abstinence at the last follow-up; (b) improvedparticipants with decreased use but not abstinence at follow-up; (c) unchanged, clean-participants who showed no sign of use at intake or follow-up;(d) unchanged, dirty-participants showing no change in use category and signs of use at both baseline and follow-up; and (e) deteriorated-participants with increased use at the last follow-up. An examination of TLFB and urine toxicology data from intake showed high levels of agreement between the two measures: 8% were negative on both, and 59% were positive on both. However, both measures detected use when the other did not: 5% of participants who self-reported no use had positive urine toxicology, and 28% of participants who had negative urine toxicology self-reported use.
Missing data strategy. About a third of cases had missing data (33% self-reported substance use, 38% urine samples, and 33% borderline personality disorder behavior) at the 12-month assessment, due in large part to hospitalizations and residential stays. Any assessments collected in these settings would have supplied misleading data on drug use and other symptoms. Before performing the analyses of clinically significant change, we used multiple imputation to recapture the missing variability (Enders, 2010; Graham, 2009) . Multiple imputation has been recommended as a "state of the art" technique to account for missing data (Schafer & Graham, 2002) because it requires fewer assumptions about the missing data mechanism. Simulation studies have shown that it typically produces more accurate estimates than other techniques (e.g., listwise deletion, mean substitution). Using simulation studies, Graham and Schafer (1999) showed that multiple imputation is effective with sample sizes comparable to the one in this study with as much as 50% missing data from most variables, even in complex models. Previous psychological and legal studies have successfully used multiple imputation with samples of comparable size to that of the current study (e.g., Maguire, 2009; Wimberly, Carver, Laurenceau, Harris, & Antoni, 2005) . Multiple imputation uses a regression-based procedure to generate multiple copies of the data set, each with different estimates of the missing values. We used Norm 2.03 (Schafer, 1997) to generate 100 imputed data sets for substance use and 100 for borderline personality disorder behavior. These were imputed separately because of the ratio of variables to be imputed to sample size. Exploratory analyses suggested that the data sets be separated by 925 iterations for substance use and 196 iterations for borderline personality disorder behavior. The imputation model included important information, including residential hospitalization at 12 months, baseline depression, adolescent gender, intervention condition, and the number of outpatient sessions received in addition to the outcome variables at all four time points.
After creating the imputed data sets, we estimated relationships for each of the 100 data sets and then combined parameter estimates and standard errors into a single set of results using Rubin's (1987) formula. One of the strengths of this approach is that there is variation between data sets, which allows for better estimates. This variation also results in cases falling into different categories across the different data sets, so the estimated numbers in each category were not necessarily integers. Some percentages do not sum to 100 because of rounding. We calculated effect sizes (ORs) for recovered and improved versus unchanged and deteriorated. We tested for differences by intervention condition, psychiatric severity group, and an Intervention Condition ϫ Psychiatric Severity Group interaction with ordinal regression pooled over the 100 data sets.
Borderline personality disorder behavior. For the full sample, intervention condition was not related to borderline personality disorder behavior, B ϭ 2.86, SE ϭ 6.98, p ϭ .683, 95% CI [Ϫ10. 98, 16.69] . We estimated that 62% of the adolescents in IDC and 76% in I-BAFT improved or recovered.
Subgroup analysis: Borderline personality disorder behavior. There was no difference between youths with comorbid depression and those without for borderline personality disorder behavior, B ϭ Ϫ0.28, SE ϭ 1.00, p ϭ .796, 95% CI [Ϫ2.21, 1.70]. There was no Intervention Condition ϫ Depression interaction, B ϭ Ϫ3.05, SE ϭ 7.02, p ϭ .665, 95% CI [Ϫ16.97, 10.88] . Change in borderline personality disorder behavior for each intervention condition divided by comorbid depression is shown in Figure 3 . In the nondepressed group, for I-BAFT (n ϭ 13) we estimated 7.3 (56%) were recovered; 1.1 (8%) were improved; 1.3 This document is copyrighted by the American Psychological Association or one of its allied publishers.
(10%) were unchanged, nonclinical; 1.2 (9%) were unchanged, clinical; and 2.2 (17%) had deteriorated. Also in the nondepressed group, for IDC (n ϭ 12) we estimated 6.3 (53%) were recovered; 0.1 (1%) were improved; 3.2 (27%) were unchanged, nonclinical; 0.1 (1%) were unchanged, clinical; and 2.4 (20%) had deteriorated. Low-severity adolescents in I-BAFT had greater odds (OR ϭ 1.58) of recovering or improving compared with IDC. In the depressed group, for I-BAFT (n ϭ 7) we estimated 3.4 (48%) were recovered; 3.3 (46%) were improved; none were unchanged, nonclinical; 0.2 (3%) were unchanged, clinical; and 0.2 (3%) had deteriorated. Also in the depressed group, for IDC (n ϭ 8) we estimated 5.6 (70%) were recovered; 0.3 (4%) were improved; 0.3 (3%) were unchanged, nonclinical; 0.4 (5%) were unchanged, clinical; and 1.5 (19%) had deteriorated. High-severity adolescents in I-BAFT had greater odds (OR ϭ 5.72) of recovering or improving compared with IDC.
Substance use. For the full sample, intervention condition was not related to substance use, B ϭ Ϫ2.28, SE ϭ 1.44, p ϭ .115, 95% CI [Ϫ5.12, 0.56]. We estimated that 23% of the adolescents in IDC and 38% in I-BAFT improved or recovered.
Subgroup analysis: Substance use. There was a significant difference in substance use between youths with comorbid depression and those without, B ϭ Ϫ2.78, SE ϭ 1.16, p ϭ .018, 95% CI [Ϫ5.02, Ϫ0.02]. There was a nonsignificant trend for an Intervention Condition ϫ Depression interaction, B ϭ 2.96, SE ϭ 1.69, p ϭ .080, 95% CI [Ϫ0. 36, 6 .27]. Change in substance for each intervention group divided by comorbidity is shown in Figure 4 . In the nondepressed group, for I-BAFT participants (n ϭ 13) we estimated 1.3 (10%) were recovered; 1.0 (8%) was improved; 1.1 (8%) were unchanged, clean; 2.1 (16%) were unchanged, dirty; and 7.5 (58%) had deteriorated. Also in the nondepressed group, for IDC (n ϭ 12) we estimated 2.5 (21%) were recovered; 0.1 (1%) were improved; none were unchanged, clean; 5.2 (43%) were unchanged, dirty; and 3.2 (35%) had deteriorated. Low-severity adolescents in I-BAFT had smaller odds (OR ϭ 0.78) of recovering or improving compared with IDC.
In the group with comorbid depression, for I-BAFT (n ϭ 7) we estimated 4.2 (60%) were recovered; 1.0 (14%) was improved; none were unchanged, clean; 1.4 (20%) were unchanged, dirty; and 0.4 (6%) had deteriorated. Also in the group with comorbid depression, for IDC (n ϭ 8) we estimated 0.9 (11%) were recovered; 0.7 (9%) were improved; none were unchanged, clean; 3.3(41%) were unchanged, dirty; and 3.2 (40%) had deteriorated. Adolescents with comorbid depression in I-BAFT had greater odds (OR ϭ 11.38) of recovering or improving compared with IDC.
Unplanned residential services. The number of residential days was positively skewed with overdispersion, so a negative binomial regression analysis in Mplus was used. Residential days was not related to intervention condition, B ϭ 0.25, SE ϭ 0.34, p ϭ .473, 95% CI [Ϫ0.42, 0.91].
Subgroup analysis: Unplanned residential services. Adolescents in the depressed group were hospitalized significantly more, B ϭ 1.03, SE ϭ 0.36, p ϭ .004, 95% CI [0.34, 1.73], than those in the Figure 3 . Estimated percentages of cases with clinically significant change in borderline behavior (N ϭ 40). BPD ϭ bipolar personality disorder; recovered ϭ clinically significant improvement in behavior from baseline to 12 months and functioning in the "normal" range at 12 months; improved ϭ clinically significant improvement in behavior from baseline to 12 months but functioning in the "impaired" range at 12 months; unchanged, nonclinical ϭ no statistically reliable change in behavior from baseline to 12 months and scores in the nonclinical range at 12 months; deteriorated ϭ clinically significant worsening in behavior from baseline to 12 months; unchanged, clinical ϭ no statistically reliable change in behavior from baseline to 12 months and scores in clinical range at 12 months; I-BAFT ϭ integrative borderline personality disorder-oriented adolescent family therapy; I-BAFT Ϫ ϭ adolescents without comorbid depression in I-BAFT; I-BAFT ϩ ϭ adolescents with comorbid depression in I-BAFT; IDC ϭ individual drug counseling; IDC Ϫ ϭ adolescents without comorbid depression in IDC; IDC ϩ ϭ adolescents with comorbid depression in IDC. (N ϭ 40) . Recovered ϭ reduced use from baseline to 12 months and abstinent at 12 months; improved ϭ reduced use from baseline to 12 months but not abstinent at 12 months; unchanged, clean ϭ no use at either baseline or 12 months; deteriorated ϭ increased use from baseline to 12 months; unchanged, dirty ϭ same level of use at baseline and 12 months; I-BAFT ϭ integrative borderline personality disorderoriented adolescent family therapy; I-BAFT Ϫ ϭ adolescents without comorbid depression in I-BAFT; I-BAFT ϩ ϭ adolescents with comorbid depression in I-BAFT; IDC ϭ individual drug counseling; IDC Ϫ ϭ adolescents without comorbid depression in IDC; IDC ϩ ϭ adolescents with comorbid depression in IDC. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Discussion
This study was designed to shed light on a group of adolescents with severe psychiatric symptoms who often require intensive treatment, including considerable residential treatment. This group of adolescents is often involved in the juvenile justice system, and it is important to highlight their treatment needs and the complexity of that treatment. The results of this study add to a limited literature by reporting the results of a small randomized clinical trial of two manualized behavioral interventions for adolescents with borderline personality disorder and co-occurring substance use disorder. Although neither the I-BAFT nor the IDC interventions were specifically tailored for juvenile justice populations, both interventions sought to identify and modify triggers for substance abuse and for engagement in associated criminal behaviors. The severity of the symptoms and overlap of multiple problems are evident in the fact that almost two-thirds of the adolescents were involved in the juvenile justice system, 28% had been hospitalized or in residential treatment in the year preceding the trial, and 65% had been arrested or detained in a police station in the year prior to baseline, all of which are relatively rare in adolescents in the general population. The sample size of this study was small but consistent with the early-stage research of new, innovative treatments (Rounsaville et al., 2001 ). This study relied on the analysis of feasibility and acceptability and on the analysis of effect sizes and trends to detect promising treatment patterns worthy of further study.
The strong baseline relationship of co-occurring depression, substance use, and borderline personality disorder behavior was consistent with recent research with adolescents (e.g., Warden et al., 2012) showing a subgroup with high psychiatric severity that included internalizing problems. A difficult question to answer is whether depression preceded and contributed to the increased drug use and borderline personality disorder behavior or either greater substance use or dysfunctional borderline personality disorder behaviors may have led to a greater risk for depression. Another possibility is that these three conditions result from a single underlying genetic predisposition. Our data did not permit us to investigate the causal links between symptoms, but it is an important question for future research. What we do know is that the distinction between those adolescents with depression and those without turned out to be clinically meaningful. Over the course of the trial, we saw an association between depression and more severe symptoms, differential impact on emergency residential treatment, and an interaction with the effects of the treatment conditions. Feasibility and acceptability required looking at both withinintervention and outside-intervention indicators. Therapeutic alliance and overall dosage of therapy (i.e., the number of outpatient sessions that adolescents attended) suggested that there was a high level of feasibility and acceptability for both I-BAFT and IDC. Further, there were no differences in alliance from the adolescents' perspective between an individually oriented and a family-oriented approach. However, this interpretation must be qualified by the fact that the participants required a substantial amount of unplanned residential treatment on average. That youths had outside hospitalizations was not a surprising finding given that more than a quarter of the sample had received residential services in the year prior to entering our outpatient study. The high volume of treatment received underlines the complex treatment needs of this population. It is interesting to note that there was a very clear pattern in which IDC youths with comorbid depression attended a lower number of planned outpatient sessions than did youths in the other three subgroups and also attended a higher number of treatment/follow-up residential days of treatment. The individually oriented, 12 step-based treatment condition may have been too focused on substance use to meet treatment needs in other areas, such as depression. I-BAFT's use of DBT-derived skills-training tools for managing depression that focus on how substance use and depression could trigger each other and on teaching parents how to better support their adolescents around issues of depression may have contributed to all family members being highly involved in the outpatient treatment, particularly when depression was present.
Previous pilot work with a slightly less severe sample led us to expect some concurrent residential treatment. We incorporated treatment manual guidelines on establishing close collaboration between outpatient and residential/inpatient treatment teams. The substantial number of days of residential treatment documented in both intervention conditions in this study reinforced the importance of this collaboration even more clearly and suggested that this type of collaboration is particularly worthwhile for youths with comorbid depression. When symptom severity is high, as in this sample, the actual treatment received will likely be a combination of outpatient and residential/inpatient treatment. I-BAFT included a plan for collaboration with hospital and residential agencies, but even more specificity and collaborative planning will be needed to maximize the benefit of treatment in future iterations. One must also wonder whether an I-BAFT-based residential treatment would be efficacious, as long as it included frequent trips home to solidify gains from family therapy.
The analysis of clinical change and clinical significance suggested that the only subgroup with substantial improvement on indicators of substance use was adolescents with comorbid depression (borderline personality disorder ϩ substance use ϩ depression) who received the I-BAFT intervention. This finding is consistent with findings reported by Henderson et al. (2010) , who showed that family-based treatment was particularly effective with highseverity cases. Unlike the IDC condition, which focused almost exclusively on substance use triggers and abstinence strategies, I-BAFT was designed to address (a) co-occurring psychiatric symptoms and emotion dysregulation that is prominent in borderline personality disorder and may be exacerbated by depression and (b) family mechanisms that help the adolescents recover from substance use and depression disorders. A holistic, family-based intervention may be particularly well-suited to intervening with This document is copyrighted by the American Psychological Association or one of its allied publishers.
youths who have complex, interrelated symptoms and to overcoming the difficulty adolescents with depression have in reducing substance use during treatment. Interestingly, the I-BAFT condition was not particularly helpful with adolescents who did not have depression. In fact, these participants continued to deteriorate with respect to substance use. The IDC condition also did not lead to improved substance use in adolescents with depression, even though they received a substantial number of days of intensive residential (inpatient) treatment. It was our clinical team's experience that when residential stays were not planned for and conceptualized with the parents as a natural extension and enhancement of the outpatient treatment, each day in the inpatient setting was interpreted as a failure of treatment, causing adolescents and parents alike to lose hope in treatment.
Unlike substance use, borderline personality disorder behaviors appeared to improve more evenly in the two conditions and, for most adolescents, regardless of the existence or absence of comorbid depression. This finding suggests that some of these behaviors may be more amenable to change in adolescents with substance abuse problems than is substance use. It is important to note that the substance use measures incorporated both self-reports of use and urine samples, but the measure of borderline personality disorder behavior was only self-reported. There is as yet no direct analogue to laboratory toxicology for borderline personality disorder behaviors, but future studies should include additional measures of these behaviors. Results, though not conclusive, challenge any notion that borderline personality disorder improves as a consequence of substance use reduction or that improvement in borderline behaviors inevitably lead to substance use reductions.
This study highlighted the complexity of conducting research on outpatient behavioral treatments with adolescents with severe cooccurring symptoms, but it also showed benefits of rigorous research. It is important to document the crises and outside services received. Further, clinicians should expect that the "true" treatment that adolescents with borderline personality disorder receive is likely a hybrid of outpatient and residential/inpatient treatment. Any outpatient treatment should have a well-designed strategy for working with residential service providers and parents in preparation for an adolescent's return to the family. Just as family members of adolescents with borderline personality disorder may experience hopelessness, therapists may become discouraged by uneven progress and unexpected hospitalizations. Recommendations (Linehan, 1993 ) that a support mechanism be in place for therapists working with individuals with borderline personality disorder were reinforced by our experience.
Our most recent work on the development and testing of an adaptive methodology or strategy that can be used to systematically tailor our work with adolescents and families to their unique clinical and cultural profiles (Santisteban, Mena, & Abalo, 2013) may be a key component of future work with adolescents with borderline personality disorder and substance abuse. The adaptive strategy can be integrated into I-BAFT so that it can better address the unique circumstances (e.g., criminal activities, symptom severity that requires hospitalization or residential services) in which some but not all adolescents enter treatment. The selection of psychoeducational modules that may be best suited for subsets of the sample may help I-BAFT to address each adolescent's and family's unique needs in a more focused manner and enhances its overall efficacy. This study had several limitations. The small sample limited statistical power and the types of analyses that could be used. For example, there were differences in the dosage of residential treatment received by the youths in the study; however, we were not able to control for this in the analyses because of the small sample size. The process of data collection was difficult because of the high level of substance use and psychiatric symptoms, which resulted in multiple hospital and residential treatment placements-some during the treatment period and immediately preceding the final assessment point. The analysis of clinical and clinically significant change used multiple imputation to deal with the resulting missing data. This strategy provided the best possible estimates, but ideal data sets would have no missing data. We considered assessments at the residential sites, but family functioning and substance use data collected in a restricted environment over a long period of time would have not be comparable to data collected outside of a restricted environment.
